ASNA1 Antikörper
-
- Target Alle ASNA1 Antikörper anzeigen
- ASNA1 (ArsA Arsenite Transporter, ATP-Binding, Homolog 1 (ASNA1))
-
Reaktivität
- Human, Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser ASNA1 Antikörper ist unkonjugiert
-
Applikation
- ELISA, Immunohistochemistry (IHC)
- Produktmerkmale
- Polyclonal Antibody
- Aufreinigung
- Antigen affinity purification
- Immunogen
- Fusion protein of human ASNA1
- Isotyp
- IgG
- Top Product
- Discover our top product ASNA1 Primärantikörper
-
-
- Applikationshinweise
- IHC 1:50-1:200, ELISA 1:5000-1:10000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1.26 mg/mL
- Buffer
- PBS with 0.05 % Sodium azide and 40 % Glycerol, pH 7.4
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Target
- ASNA1 (ArsA Arsenite Transporter, ATP-Binding, Homolog 1 (ASNA1))
- Andere Bezeichnung
- ASNA1 (ASNA1 Produkte)
- Hintergrund
- ASNA1 (also known as TRC40) is a highly conserved ATPase involved in efflux of arsenite and antimonite. Reduced ASNA1 expression is associated with significant inhibition of cell growth,increased apoptosis and increased sensitivity to cisplatin and arsenite.Thus ASNA1 is proposed to be a target to overcome resistance to cancer chemotherapy. In addition,ASNA1 has been identified as an ER targeting factor for tail-anchored proteins in the posttranslational membrane insertion pathway.
- UniProt
- O43681
- Pathways
- Positive Regulation of Peptide Hormone Secretion
-